Findings from American Cancer Society Provides New Data on Cancer (Health Insurance Coverage Disruptions and Access To Care and Affordability Among Cancer Survivors In the United States)

2020 DEC 24 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Current study results on Cancer have been published. According to news reporting out of Atlanta, Georgia, by NewsRx editors, research stated, “Lack of health insurance is associated with having problems with access to high-quality care. We estimated prevalence and evaluated associations of insurance coverage disruptions and access to health care and affordability among cancer survivors in the United States.”

Financial support for this research came from AstraZeneca.

Our news journalists obtained a quote from the research from American Cancer Society, “Adult cancer survivors ages 18 to 64 years with current private or public health insurance were identified from the 2011 to 2018 National Health Interview Survey (n = 7,186). Health insurance coverage disruption was measured as self-reports of any time in the prior year without coverage. Outcomes included preventive services use, problems with care affordability, and cost-related medication nonadherence in the prior year. We used separate multivariable logistic models to evaluate associations between coverage disruptions and study outcomes by current insurance coverage. Among currently insured survivors, 3.7% [95% confidence interval (95% CI), 3.0%-4.4%] with private, and 7.8% (95% CI, 6.5%-9.4%) with public insurance reported coverage disruptions in 2011 to 2018. We estimated that approximately 260,000 survivors ages 18 to 64 years had coverage disruptions in 2018. Among privately and publicly insured survivors, those with coverage disruptions were less likely to report all preventive services use (16.9% vs. 36.2%; 14.6% vs. 25.3%, respectively) and more likely to report any problems with care affordability (55.0% vs. 17.7%; 71.1% vs. 38.4%, respectively) and any cost-related medication nonadherence (39.4% vs. 10.1%; 36.5% vs. 16.3%, respectively) compared with those continuously insured (all P< 0.05). Coverage disruptions in the prior year were associated with problems with health care access and affordability among currently insured survivors.”

According to the news editors, the research concluded: “Reducing coverage disruptions may help improve access and affordability for survivors.”

This research has been peer-reviewed.

For more information on this research see: Health Insurance Coverage Disruptions and Access To Care and Affordability Among Cancer Survivors In the United States. Cancer Epidemiology Biomarkers & Prevention, 2020;29(11):2134-2140. Cancer Epidemiology Biomarkers & Prevention can be contacted at: Amer Assoc Cancer Research, 615 Chestnut St, 17TH Floor, Philadelphia, PA 19106-4404, USA.

Our news journalists report that additional information may be obtained by contacting Jingxuan Zhao, American Cancer Society, Surveillance & Hlth Serv Res Program, Atlanta, GA 30329, United States. Additional authors for this research include Xuesong Han, Leticia Nogueira, Zhiyuan Zheng, Ahmedin Jemal and K. Robin Yabroff.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1158/1055-9965.EPI-20-0518. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)